Step Pharma logo

Step Pharma

Website
Current Valuation
N/A
As of October 15, 2025
Total Funding Raised
$112.0M
Last Round
Later Stage VC

$44.5M

Last Funding
Oct 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Step Pharma is currently valued at N/A as of October 15, 2025. The company has raised a total of $112.0M in funding.

Investment Perspective

Step Pharma's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Step Pharma Valuation Updates

Get notified when Step Pharma raises new funding or valuation changes

Explore More Data
Detailed analysis for Step Pharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is Step Pharma Worth in 2025?

As of 2025, Step Pharma is valued at N/A, based on the company's Later Stage VC funding round in October 15, 2025. This valuation positions Step Pharma as one of the leading private companies in the sector.

Step Pharma Valuation History

Step Pharma's funding history demonstrates steady growth and investor confidence.

How Step Pharma Valuation is Determined

Private company valuations like Step Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Step Pharma Valuation FAQs

Is Step Pharma profitable?

Step Pharma has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Step Pharma's valuation compare to competitors?

Step Pharma is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Step Pharma IPO?

Step Pharma has not announced plans for an initial public offering. Until an IPO, investors can access Step Pharma shares through secondary market platforms.